Summary
- Yet, for many women, the fear of discovering something wrong can become a reason to delay seeking medical help.
- It is this fear that awareness seeks to overcome, reminding women that paying attention to their health and seeking timely medical advice can make all the difference.
- Their experience offered a powerful reminder that health initiatives can have a meaningful impact beyond the seminar room, encouraging people to seek medical advice when it matters most.
AI Generated Summary
Sometimes, the most powerful stories are not about the fear of losing hope, but the courage to hold on to it. A woman’s journey through breast cancer, a doctor’s words of reassurance and the promise of a healthier tomorrow came together at a breast cancer awareness seminar organised by DHA Karachi at DHA Creek Club.
Behind every diagnosis is a human story — of uncertainty, courage, family and the determination to keep going. Yet, for many women, the fear of discovering something wrong can become a reason to delay seeking medical help. It is this fear that awareness seeks to overcome, reminding women that paying attention to their health and seeking timely medical advice can make all the difference.
The need for greater awareness is reflected in figures from the World Health Organization’s International Agency for Research on Cancer. According to GLOBOCAN 2022 estimates, approximately 30,682 women in Pakistan were diagnosed with breast cancer in 2022, making it the most commonly diagnosed cancer among women in the country. Globally, around 2.3 million women were diagnosed with the disease that year, highlighting the importance of early detection, accessible healthcare and timely treatment.
Addressing the participants, Dr Nida Wahid, Surgeon, emphasised that fear should never stand in the way of seeking medical advice. She encouraged women to become familiar with their bodies and consult a healthcare professional if they notice unusual changes, rather than allowing anxiety or uncertainty to delay an assessment.






Comments
0 commentsNo comments yet — be the first.